Navigation Links
ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders
Date:9/6/2010

sented at EURETINA Highlight the Attractive Characteristics of this Novel Potential Treatment Option for Retinal Disorders

ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France. The MIVI-TRUST program is the largest interventional clinical program ever performed to specifically evaluate the vitreoretinal interface in patients with retinal disorders, recruiting a total of 652 patients at 90 centers across the U.S. and Europe.

The pooled results of the TG-MV-006 and TG-MV-007 Phase III trials were presented by Prof. Peter Stalmans (University Hospitals Leuven, Belgium). These results demonstrate the potential of microplasmin to transform the treatment of a range of retinal disorders.

The Phase III program showed that microplasmin: - Was successful in resolving vitreomacular adhesion (VMA) - Was able to cure full thickness macular hole (FTMH) without the need for surgery - Delivered an improvement in the vision of patients without the need for surgery - Was safe and well tolerated

Both the TG-MV-006 and TG-MV-007 trials met the primary endpoint, achieving a statistically significant improvement in the resolution of VMA. The pooled results from the MIVI-TRUST program showed that 26.4% of the 465 microplasmin treated patients achieved resolution of their VMA at 28 days, compared to 10.2% of the 182 patients who received a placebo injection, a highly statistically significant result (p=0.000002).

In patients without epiretinal membrane, microplasmin was shown to be even more effective, with 37.4% of 270 patients achieving nonsurgical resolution of their VMA at 28 days, compared to 14.3% of 119 placebo
'/>"/>

SOURCE ThromboGenics NV
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
2. ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
3. ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
4. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
5. ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
6. ThromboGenics Microplasmin Phase III Program Progressing According to Schedule
7. ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402
8. ThromboGenics Completes Patient Enrolment in US Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease
9. ThromboGenics and BioInvent Complete Patient Recruitment of Phase II DVT Prophylaxis Study With Anti-Factor VIII (TB-402)
10. ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease
11. ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Heart Valve 2007 to 2020 - Europe ( ... UK, Spain ) Summary GBI Research,s report, "Market ... ( Germany , France , Italy ... transcatheter heart valves market in Europe . The analysis includes ... company share data by revenue in 2013 for the following countries: ...
(Date:9/23/2014)... , Sept. 23, 2014  SI-BONE, Inc., a ... iFuse Implant System, ® a minimally invasive surgical ... joint, today announced that the U.S. Patent and Trademark ... systems and methods for the fixation and fusion of ... fenestrated implant with a tapered distal end that may be placed from ...
(Date:9/23/2014)... 2014  Global Discovery Biosciences, a laboratory dedicated to ... biggest healthcare challenges, announces their collaboration with IPMD, Inc. ... for the early detection of lung cancer. ... Typically, the symptoms and subsequent diagnosis of lung cancer ... chance of a cure has already passed. Early screening ...
Breaking Medicine Technology:Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain) 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 2SI-BONE, Inc. Strengthens Patent Portfolio with the U.S. Patent and Trademark Office's Issuance of Threaded, Fenestrated Implant Method Patent 3Global Discovery Biosciences Announces Collaboration with IPMD, Inc. to Develop Innovative Aptamer-Based Blood Test for the Early Detection of Lung Cancer 2
... , May 6 Intercell AG (VSE: ICLL) today announced ... Cytos, platform technology for monoclonal antibody discovery. The technology is based on ... of anti-infective antibodies to prevent and treat infectious diseases. , ... Under the agreed terms Intercell will pay ...
... MILWAUKEE , May 5 Children,s Hospital of ... one of two in a pediatric hospital in the nation. ... the top-rated pediatric hospitals in the country. The Variety Orthopedic ... aid in treating children with scoliosis and other chronic orthopedic ...
Cached Medicine Technology:Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases 2Children's Hospital of Wisconsin One of Two Pediatric Hospitals in Nation to Implement EOS Scanner 2Children's Hospital of Wisconsin One of Two Pediatric Hospitals in Nation to Implement EOS Scanner 3Children's Hospital of Wisconsin One of Two Pediatric Hospitals in Nation to Implement EOS Scanner 4
(Date:9/23/2014)... PA (PRWEB) September 23, 2014 "The primary ... infection control," said an inventor from Sacramento, Ca.. "Call lights ... bedding or left hanging on the IV pole out of ... have the nurse call device whenever they need it, I ... to effectively position the nurse call device within easy reach. ...
(Date:9/23/2014)... From first-hand experience, Matthew O'Farrell knows all about ... can be treated. , A medically retired Army veteran, ... platoon sustained multiple attacks resulting in five casualties. After ... PTSD and honorably discharged from the Army. , “I ... myself from my friends and family,” recalled O’Farrell, who ...
(Date:9/23/2014)... HealthDay Reporter TUESDAY, Sept. 23, 2014 ... for providing better care, not more ... choices. A new report suggests that,s the direction ... the IMS Institute for Healthcare Informatics in Parsippany, N.J., identifies ... the delivery of health care and use of medicines over ...
(Date:9/23/2014)... What information do patients need to ... (NQF) released a report ( http://bit.ly/1DwekE9 ), consumer ... ( http://bit.ly/1tX3lzA ) resulting from an in-depth look ... define affordability, and what information and changes are ... healthcare at the lowest possible cost. ...
(Date:9/23/2014)... A recent Oregon survey about an exercise DVD that ... routine of elementary school students found it had a ... and offered clear advantages for overly sedentary educational programs. ... produced by the Healthy Youth Program of the Linus ... nationally. , Brain Breaks leads children in 5-7 minute ...
Breaking Medicine News(10 mins):Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3
... ... ... ... ...
... For some Canadians, any cut such as from dental ... Although they are not hemophiliacs, for some an ordinary bruise ... knees, elbows and ankles are crippled when bleeding seeps into ... required for recovery. Now a team led by ...
... recovery for people with disabilities following major natural disasters, ... in the International Journal of Emergency Management . ... other natural disasters, and even technological emergencies it has ... disaster and emergency preparedness for people with disabilities. Following ...
... will take place at the University of Haifa on Monday, ... sessions and dozens of lectures presenting studies that encompass the ... "This is a wide phenomenon that touches many audiences and ... and its various disciplines have found it worthy of attention ...
... ... ... -- As Maryland Gov. Martin O’Malley proposes cutting $123 million from Medicaid for the 2011 ... by Dr. Todd Eberly, assistant professor of political science and coordinator of public policy studies ...
... may benefit those with aura, researchers say , THURSDAY, March ... magnetic pulse to the head may offer relief for some ... migraine sufferers who experience "aura," expand on previous research by ... only at the doctor,s office. , It,s unclear, however, how ...
Cached Medicine News:Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 2Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 3Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 4Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 5Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 6Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 7Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 8Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 9Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 10Health News:Genetic cause discovered for rare bleeding disorder 2Health News:Emergency online communities 2Health News:Proposed Medicaid Cuts Threatens Health Care Access for 400,000 Maryland Children 2Health News:Proposed Medicaid Cuts Threatens Health Care Access for 400,000 Maryland Children 3Health News:New Hope for Migraine Patients 2
Solid steel construction for lifelong quality. Strong, smooth and quiet electro-mechanical up/down movement. Dual castor, locking wheels for use on carpet or tile flooring. Easy cleaning, deluxe lami...
Trial lens set +/- Cyl....
... Contemporary Soft Touch control panel with ... Pebble Gray, Noir Black, Colonial Blue and ... arms. Durable cast iron and steel construction ... smooth, quiet and reliable up/down chair movement. ...
Our Ophthalmic Diagnostic Sets offer everything an eye care specialist needs. Complete your set with your choice of ophthalmoscope, retinoscope, handle, and case....
Medicine Products: